Article

Rheumatology Network's Top 5: April 2, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending April 2, 2022.

Coffee Consumption Reduces Risk of Gout

“The effects of coffee consumption on SUA levels and gout risk are controversial,” investigators explained. “There have hitherto been no reports based on its effects that consider pleiotropy.”

COVID-19 Linked to More Severe Lung Outcomes in Patients With Rheumatic Disease

Patients with rheumatic disease were more likely to have a Pulmonary X-Ray Severity score >9, were more likely to require mechanical ventilation, and had a higher risk of death when compared with controls.

Adverse Experiences Negatively Impact Symptomology of Childhood Rheumatic Disease

Chronic stressors may play an important role in the development of chronic pain, leading to excess cortisol production and disruption to the body's sympathetic and parasympathetic systems.

Golimumab Improves Disease Activity in Patients With RA

“[Some] Patients may benefit from switching to a fully human biologic, such as IV-golimumab, to control disease activity/improve drug tolerance," investigators stated.

Patients With RA Less Likely to Receive Influenza Vaccination

Influenza vaccination rates remain low within patients with rheumatoid arthritis. Investigators urge rheumatologists to encourage vaccination acceptance as a part of routine care.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.